| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647231 | Multiple Sclerosis and Related Disorders | 2018 | 4 Pages |
Abstract
Brain atrophy, especially than in the GM, is a major determinant of DTC, although other pathological markers also contribute to CMI in patients with MS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Giancarlo Coghe, Giuseppe Fenu, Lorena Lorefice, Erica Zucca, Micaela Porta, Giuseppina Pilloni, Federica Corona, Jessica Frau, Maria Giovanna Marrosu, Massimiliano Pau, Eleonora Cocco,